Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
03/16/2005 | CN1593654A Human lysozyme suppository, preparation method and application |
03/16/2005 | CN1593630A Ointment and its application |
03/16/2005 | CN1593607A Medicinal capsule for treating pelvic inflammatory disease and its preparing process |
03/16/2005 | CN1593605A Dispersible tablet for pelvic inflammatory disease and its preparation |
03/16/2005 | CN1593604A Dispersible tablet for treating mammary glands hyperplasia and its preparing method |
03/16/2005 | CN1593603A Emmeniopathy treating Chinese medicinal capsule and its preparation |
03/16/2005 | CN1593599A Ointment for dispersing breast nodules and preparation method thereof |
03/16/2005 | CN1593596A Compound formulation for treating functional menoxenia and its application in pharmacy |
03/16/2005 | CN1593565A Medicine for treating dysmenorrhea and its preparing method |
03/16/2005 | CN1593555A Indiscerptible and built in type Chinese traditional preparation for gynecopathy and its preparation process |
03/16/2005 | CN1593543A Method for preparing compound Chinese medicinal tonifying liquor |
03/16/2005 | CN1593533A 'Huahong' dispersible tablet for treating gynecological inflammation and its preparing method |
03/16/2005 | CN1593531A Angelica and herbaceous peony root contained capsule for regulating menstruation and its preparation process |
03/16/2005 | CN1593527A Dispersible tablet of 'Duyiwei' and its preparing method |
03/16/2005 | CN1593526A Chinese herbal medicinal injection for treating animal mastitis and its preparing method |
03/16/2005 | CN1593524A Mastopathia treating Chinese traditional medicinal tablet and its preparation process |
03/16/2005 | CN1593519A Method for preparing a gynecopathy treating medicine |
03/16/2005 | CN1593518A Method for preparing a gynecopathy treating medicine |
03/16/2005 | CN1593517A Method for preparing a gynecopathy treating medicine |
03/16/2005 | CN1593516A Method for preparing a gynecopathy treating medicine |
03/16/2005 | CN1593515A Method for preparing a gynecopathy treating medicine |
03/16/2005 | CN1593514A Method for preparing a gynecopathy treating medicine |
03/16/2005 | CN1593510A Method for preparing Chinese medicinal formulation of dog button |
03/16/2005 | CN1593502A Snake slough pills and its prescription |
03/16/2005 | CN1593500A Kidney benefiting, Chong collateral reinforcing and menstruation regulating hemostat |
03/16/2005 | CN1593499A Medicine for treating boil, acute mastitis and acute inflammation |
03/16/2005 | CN1593451A Externally applied medicine for promoting male erection |
03/16/2005 | CN1593443A Medical phytoestrogen |
03/16/2005 | CN1593408A Alkaloids sophora flavescen pellicle and its preparation process |
03/16/2005 | CN1593407A Matrine pellicle and its preparation process |
03/16/2005 | CN1593399A Application of compound laetispicine in the process for preparing pharmaceutical composition |
03/16/2005 | CN1593396A Liquor for increasing cow born ratio and its manufacturing method |
03/16/2005 | CN1593386A Temperature sensitive gel formulation for in situ vagina uses |
03/16/2005 | CN1193026C Z-pyrazoline-5-ones |
03/16/2005 | CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same |
03/16/2005 | CN1192785C Haemostatic 'Gonghuan' tablet and preparing process |
03/16/2005 | CN1192784C Use of pubescent holly root extract in preparing erection disfunction treating drug |
03/16/2005 | CA2480218A1 New derivatives of benzoindoline, preparation thereof, and pharmaceutical compounds containing them |
03/15/2005 | US6867220 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
03/15/2005 | US6867003 Grb14, Grb14 fusion proteins, and screening methods |
03/15/2005 | US6866872 Withania somnifera Dunal extracts for increasing male sperm count |
03/15/2005 | CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones |
03/15/2005 | CA2191769C Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents |
03/10/2005 | WO2005021016A1 A pharmaceutical composition for treating hypermenorrhea and preparation method thereof |
03/10/2005 | WO2003104260A3 Pharmaceutical formulation |
03/10/2005 | US20050055735 Use of complement protein C3 and its derivatives in enhancing mammalian embryo development |
03/10/2005 | US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
03/10/2005 | US20050054711 with a substituted benzene ring; agonists of the progesterone receptorinducing contraception treating progesterone-related carcinomas and adenocarcinomas |
03/10/2005 | US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases |
03/10/2005 | US20050054698 4-(4Methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3) |
03/10/2005 | US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders |
03/10/2005 | US20050054641 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same |
03/10/2005 | US20050054623 Transdermal supplying testosterone gel |
03/10/2005 | US20050054595 Genetic engineering; gene expression of target agent |
03/10/2005 | US20050054593 New drug |
03/10/2005 | US20050054576 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy |
03/10/2005 | US20050054036 Growth factor isoform |
03/10/2005 | US20050053601 Protein with amino acid sequences for central nervous systems in mammals |
03/10/2005 | CA2535522A1 Fsh glycosylation mutant |
03/09/2005 | EP1512739A1 Chrondrocyte therapeutic delivery system |
03/09/2005 | EP1512687A1 Piperazines as oxytocin agonists |
03/09/2005 | EP1512016A1 Screening method and anti-tumor drug candidate obtained therefrom |
03/09/2005 | EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
03/09/2005 | EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators |
03/09/2005 | EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors |
03/09/2005 | EP1511736A1 Therapeutic molecules and methods-1 |
03/09/2005 | EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
03/09/2005 | EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
03/09/2005 | EP1511727A2 Aromatic sulfones and their medical use |
03/09/2005 | EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
03/09/2005 | EP1511537A2 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
03/09/2005 | EP1511514A1 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus |
03/09/2005 | EP1511497A1 Treatment of post-menopausal complaints in breast cancer patients which comprises tibolone and a serm |
03/09/2005 | EP1511495A1 Progestagenic dosage units |
03/09/2005 | EP1511489A1 New pharmaceutical compositions containing flibanserin polymorph a |
03/09/2005 | EP1511488A2 Human adam-10 inhibitors |
03/09/2005 | EP1511484A1 Combination of a dpp iv inhibitor and a cardiovascular compound |
03/09/2005 | EP1255552B1 Prostaglandin compositions for the treatment for male erectile dysfunction |
03/09/2005 | EP1137423B1 Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
03/09/2005 | EP0876612B1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
03/09/2005 | CN1592745A Therapeutic chromone compounds |
03/09/2005 | CN1592743A Inhibitors of glycogen synthase kinase 3 |
03/09/2005 | CN1592616A GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
03/09/2005 | CN1592600A Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
03/09/2005 | CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof |
03/09/2005 | CN1589897A Biological immune preparation for treating dairy cattle clinical mamitis and its manufacturing method |
03/09/2005 | CN1589894A Medicinal composition for treating parafunctional metrorrhagia and its preparation method |
03/09/2005 | CN1589884A External use Chinese medicinal lotion for treating gynecopathy inflammation |
03/09/2005 | CN1589880A Traditional Chinese modicine for treating gynecopathy and its preparation method |
03/09/2005 | CN1589877A Ready prepared Chinese medicine for treating angeitis and preparation process |
03/09/2005 | CN1589866A External use Chinese medicinal preparation for treating gynecopathy and its manufacturing method |
03/09/2005 | CN1589848A Anti inflammatory bacteria inhibiting medicinal composition and its preparation method |
03/09/2005 | CN1589820A Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method |
03/09/2005 | CN1589801A Progesterone liquid capsule and its preparation method |
03/09/2005 | CN1589786A Composite effervescent preparation containing soya isoflavone |
03/09/2005 | CN1192021C 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands |
03/09/2005 | CN1191849C Chinese medicine for treating breast disease |
03/08/2005 | US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders |
03/08/2005 | US6864253 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders |
03/08/2005 | US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer |